Mutations at 18 loci which map to five linkage groups in Dictyostelium discoideum are shown to affect resistance to antimicrotubule agents (including coumarin). The resistance or sensitivity mutations are classified according to whether their effects are limited to antimicrotubule agents, or whether cross-resistance or sensitivity to other compounds (notably acriflavin and cycloheximide) is observed. The latter class is likely to include mutations affecting permeability and is probably not of interest in the search for mutations directly affecting the cytoskeleton. All four acriflavin-resistance loci (acrA to acrD), many coumarin-sensitivity loci (couB to couE, coui), and both arsenate-resistance loci (arsA, arsB) fall into this category. Many mutants isolated on the basis of resistance to antimicrotubule agents (e.g. benlate, thiabendazole) in fact map at acrA or acrC. Some mutations affecting resistance to microtubule inhibitors also affect spore shape. Analysis of mutations such as couG370 and couH361, which affect coumarin sensitivity, spore shape, temperature sensitivity and, in the case of couH36 1, thiabendazole sensitivity provides the possibility of an ultrastructural approach to the study of the cytoskeleton in D. discoideum.
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Mutations at 18 loci which map to five linkage groups in Dictyostelium discoideum are shown to affect resistance to antimicrotubule agents (including coumarin). The resistance or sensitivity mutations are classified according to whether their effects are limited to antimicrotubule agents, or whether cross-resistance or sensitivity to other compounds (notably acriflavin and cycloheximide) is observed. The latter class is likely to include mutations affecting permeability and is probably not of interest in the search for mutations directly affecting the cytoskeleton. All four acriflavin-resistance loci (acrA to acrD), many coumarin-sensitivity loci (couB to couE, coui), and both arsenate-resistance loci (arsA, arsB) fall into this category. Many mutants isolated on the basis of resistance to antimicrotubule agents (e.g. benlate, thiabendazole) in fact map at acrA or acrC. Some mutations affecting resistance to microtubule inhibitors also affect spore shape. Analysis of mutations such as couG370 and couH361, which affect coumarin sensitivity, spore shape, temperature sensitivity and, in the case of couH36 1, thiabendazole sensitivity provides the possibility of an ultrastructural approach to the study of the cytoskeleton in D. discoideum.
I N T R O D U C T I O N
Microtubules are key elements in the mitotic spindle and are also involved in maintaining cell shape and in morphogenesis (Dustin, 1978) . While there have been extensive studies on the biochemistry of tubulin, only limited genetic analysis has been reported, primarily in Aspergillus nidulans (Sheir-Neiss et al., 1978; Oakley & Morris, 1981; Morris et al., 1979 Morris et al., , 1982 , Drosophila melanogaster (Kemphues et al., 1979) , and Chinese hamster ovary (CHO) cells (Cabral et al., 1980; Keates et al., 1981) . In these organisms mutations in structural genes for a /3-subunit of tubulin have been identified, as has the a-subunit in A. nidulans (Morris et al., 1979) . More generally, it should be possible to study other loci associated in some way with tubulin on the basis of mutants resistant or sensitive to microtubule inhibitors (Van Tuyl, 1977; Morris et al., 1982) .
There have been a number of studies in the cellular slime mould Dictyostelium discoideum using microtubule inhibitors (including colchicine, nocodazole, thiabendazole, cambendazole, benomyl, CIPC, and coumarin) which demonstrate effects on the mitotic spindle, cytoskeleton and development (Cappuccinelli & Ashworth, 1976; Zada-Hames, 1977 ; O'Day & Durston, 1978; Cappuccinelli et al., 1979; Welker & Williams 1980a , 1982a White et al., 1981 ; Welker, 1982) .
Resistance mutations rather than auxotrophic mutations have played an important role in constructing a genetic map in D. discoideum (Welker & Williams, 19823; Newell, 1982) . For this reason, a number of genetic loci are known in which mutations alter resistance to microtubule inhibitors (Williams et al., 1974; Williams & Barrand, 1978; White et al., 1981; Welker & Williams, 1980c , 1982a Welker, 1982) . Here we examine previously described mutations, and a series of new mutations, in an attempt to classify them either as H P5  HP11  HPS80  HR7  HU413  HU526  HU606  HU608  HU609  HU610  HU694  HU877  HU970  HU1043  HU1048   H u l l 0 8  HU1121  HU1136   HU 1206  HU 1662  HU 1663  HU 1727  HU 1920  HU1973  HU1974   M28  M146  NP15  NP187  TS12  XP222   Parentt   x 2  x 2  DPS25  HR6  HU407  DU740  HU526  HU526  HU526  HU526   DU 1223  HU876  AX3  AX3  AX3  AX3  DU1461   DU 1739  DU2348  DU2352  DU235 1  DU2514   DU 1088  DU1088   NC4  M1  M28  NP20  NC4  DP acrA, altered resistance to acriflavin (100 pg ml-l), methanol (2 to 379, and/or benzimidazole derivatives; acrB, acrC, acrD, altered resistance to acriflavin (100 pg ml-l) and/or benzimidazole derivatives; agg, defective in aggregation; axe, ability to grow in axenic media; ben, altered resistance to benomyl; bsg, inability to grow using Bacillus subtifis as a food source; bwn, production of brown pigment during development; cob, resistance to cobaltous chloride (300 pg ml-l); cou, sensitivity to coumarin (1.3 mM); cyc, resistance to cycloheximide (500 pg ml-l); ebr, resistance to ethidium bromide (25 pg ml-I); manA, a-mannosidase-1-deficient; rad, sensitivity to irradiation with (1982) .
permeability mutations or as mutations that specifically affect microtubules. This classification is based on examination of cross-resistance to the compounds acriflavin or cycloheximide, which do not affect microtubules.
METHODS
Growth of amoebae and genetic analysis. Standard techniques were used to grow Dictyostelium discoideum and to construct diploid strains and haploidize them (Welker & Williams, 1980c , 1982a , 1982b . Haploid strains used in this work are described in the text and Table 1 .
Chemicals. Coumarin (1,2-benzopyrone), cycloheximide and isopropyl N-(3-~hlorophenyl)carbamate (CIPC) were obtained from Sigma. Benlate was a gift from DuPont; methanol and cobaltous chloride were analytical reagent grade from May & Baker. Thiabendazole and cambendazole (both 97% pure) were gifts from William Bliss of Merck, Sharp & Dohme, Research Labs, Ingleburn, N.S.W., Australia.
Inhibitor-containing media. The SM agar and most inhibitor concentrations have been described previously (Welker & Williams, 1982a , 1982b , except that media containing coumarin (1.3 mM) were prepared using Difco bactopeptone, since it was found that coumarin sensitivity was more pronounced on this medium (Welker and Williams, 1982~) . For resistance assays, thiabendazole (10 pg ml-I) and CIPC (5 pg m1-I) were added to SM agar immediately before pouring plates from stock solutions (20 mg ml-I) in dimethylformamide, which were stored at -20 "C. For haploidization, thiabendazole (2 pg ml-l), CIPC (1 pg ml-l), or benlate (20 to 50 pg ml-l) were used. Benlate (20 to 600 pg ml-l) was usually added as a powder to SM agar after autoclaving, while coumarin was added to the agar before autoclaving.
Photography of spores. Spores were harvested from stock plates, washed once in water, fixed in methanol/acetic acid, stained with Gurr's Giemsa stain and photographed using bright-field optics as described by Brody & Williams (1974) for chromosome staining.
RESULTS AND DISCUSSION
We propose here that mutants of D. discoideum with altered resistance to microtubule inhibitors (including coumarin, Welker & Williams, 1982a ) fall into two broad classes, those involved with cell permeability or uptake and those having a more specific effect. The altered permeability class might be expected to show cross-resistance or sensitivity to unrelated compounds, and we identify them on this basis using acriflavin (100 to 150pgml-') or cycloheximide (500 pg ml-l) as the unrelated compounds. Mutations defining loci at which no cross-resistance to unrelated compounds is detected are of particular interest as they are candidates for the tubulin structural genes, microtubule-associated proteins, or proteins involved in some way with microtubule organization. It is noteworthy that many of the 'specific' mutants have growth temperature-sensitivity phenotypes associated with the microtubule resistance or sensitivity (this paper; White et al., 1981; Sheir-Neiss et al., 1978) .
Acriflavin resistance mutations show cross-resistance to microtubule inhibitors
We find that at least some alleles at all four acr loci show cross-resistance to benomyl (benlate) and/or t hiabendazole.
acrA . These mutations were initially isolated in strains exposed to acriflavin, acriflavin followed by counterselection on thiabendazole, or methanol (Williams et al., 1974) . Subsequently, it was shown that the acrA locus is probably the only locus with a methanolresistance phenotype (Williams, 1976) . The resistance of acrA mutations to microtubule inhibitors is variable, although some generalizations can be made ( Table 2 ). Mutants that are highly resistant to methanol [i.e. grow at almost normal rates on 2% (v/v) methanol-SM agar] are also resistant to acriflavin, benlate, thiabendazole (Table 2 ) and CIPC (data not shown). However, weakly methanol-resistant mutants (e.g HU366, HU368 and to some extent HU349, Table 2 ), while still bearing mutations at the acrA locus on the basis of failure to complement the methanol resistance of an established acrA mutation, are likely to show wild-type resistance or even sensitivity (e.g. HU368 on cambendazole) to acriflavin and microtubule inhibitors. Podgorsky & Deering (1980) have also observed differences in the acriflavin resistance of 
(1 00 IJ-g ml-I) S R R RS S S S, sensitive, less than 1 % plating efficiency, essentially no growth; R, resistant, high plating efficiency (> 2079, considerable growth and fruiting; RS, resistant, but slow growth and often poor fruiting body formation; SR, partially resistant, extremely slow growth, colonies appear but do not grow appreciably although the plating efficiency is usually high (> 10%). Plating efficiency refers to percentage of colonies on inhibitor-containing medium compared to controls (SM agar) which always have close to 100% viability.
* All inhibitors were included in SM agar after autoclaving. Note that the inhibitory concentrations vary
depending on the precise nature of the growth medium. For example the experiments reported here were done in Australia. Experiments done in Munchen under similar conditions, required 150 pg acriflavin ml-' for the same toxicity.
t Development impaired, failure to aggregate or sparse fruiting body formation.
methanol-resistant mutants. Some mutants carrying spontaneous acrA mutations also show developmental defects which are exaggerated on media containing methanol or benlate (e.g. HU368, Table 2 ). Hence the phenotype of alleles at the acrA locus varies widely in regard to cross-resistance and developmental effects. acrB. Only a single allele acrB3, is known at this locus (Williams et al., 1974) . Strain NP15 (acrB3) was more resistant to benlate (30% plating efficiency at 50 pg ml-l) than its parent, M28, which was sensitive to 20 pg benlate ml-I. Since NP15 is a spontaneous mutant, the enhanced resistance to this microtubule inhibitor is almost certainly due to the acrB3 mutation.
acrC. The benlate resistance of the acrC4 strain HR7 (Rothman & Alexander, 1975 ) is greater than that of its parent, AX3, since it forms larger, faster-growing colonies than AX3 on media containing benlate. However, strain AX3 itself is relatively resistant to benlate. Colonies of AX3 form at close to 100% plating efficiency on 600 pg benlate ml-l, although they do not grow to diameters of more than 1 mm. Diploids homozygous for the acrC4 mutation are resistant to haploidization by benlate, CIPC and thiabendazole at the standard concentrations (20 to 50 pg benlate ml-l, see Williams & Barrand, 1978 ; 1 pg CIPC ml-l; 2 pg thiabendazole ml-l). Four other alleles at the acrC locus have been assigned by us on the basis of mapping to linkage group 111 and failure to complement the acriflavin-resistance phenotype of the acrC4 mutation. Two of these were isolated as benlate-resistance mutations in strains HP5 (ben-550, renamed acrC55O) and HPl 1 (ben-551, renamed acrC551) by Drs Barrand and Brachet (Pasteur Institute, Paris; see Williams & Barrand, 1978) . The other mutations, acrC388 in strain HPS80 and acrC1805 in strain HU694, have been described elsewhere (Welker & Williams, 1982 b) . Diploids homozygous for acrC338 or acrCl805 were resistant to haploidization by thiabendazole and benlate.
acrD. The acrD locus is defined by two alleles acrD 18 17 and acrD369 (see below), which were both discovered in strains being analysed for other reasons. The acrD 1817 allele in strain HU877 showed cross-resistance to benlate and CIPC.
Genetic background efSects on sensitiuity to benlate
Although virtually all D. discoideum genetics is done on strains derived from a single isolate (strain NC4), the genetically marked strains carry a considerable genetic load due to Table 3 . Plating eficiency of coumarin-sensitive haploids on medium containing cycloheximide Plating efficiency was determined as the ratio of the colony-forming ability on SM medium containing 500 pg cycloheximide ml-' to that on SM medium without cycloheximide. Genetic background effects on suppression of cycloheximide resistance were observed with haploids bearing the couD355 or cou1392 mutation. Since HU1920 (cou1392) carries linkage groups I, 111, VI and VII of XP222, the suppression of cycloheximide sensitivity in XP222 lies on linkage group 11, IV or V. (Welker et al., 1982) . In particular, differences were noted in the sensitivity of 'wild-type' strains to microtubule inhibitors. Strain M28 (Katz & Sussman, 1972 ) is much more sensitive to benlate than other 'wild-type' strains, in that it has a low plating efficiency and barely grows on 20 pg benlate m1-I. The mutation involved (ben-360) possibly maps to linkage group IV. Strains bearing the radB 13 mutation also carry a benlate-sensitivity mutation (ben-359) on either linkage group 111 or VI which adversely affects the recovery, using benlate, of haploid segregants carrying it (Welker & Williams, 1981) .
Coumarin
Some coumarin-sensitivity mutations alter cycloheximide resistance In the course of analysing coumarin-sensitivity mutants which also carried cycloheximideresistance mutations at the cycA locus, we observed that five showed partial sensitivity to 500 pg cycloheximide ml-l. On this basis we ascribe the mutations in these strains to alterations in uptake or membrane-associated functions. Haploid strains carrying the couB352, couC356, couD355, couE353 or the cod392 mutation were in this class (Table 3) . It was observed that the cycloheximide sensitivities associated with the couD355 and couI392 mutations were suppressible in some genetic backgrounds (Table 3) .
Since the cou-392 mutation is controversial, we have mapped it here. Wallace & Newel1 (1982) claimed that the coumarin sensitivity of strain XP222 mapped to linkage group VII and was most likely due to the presence of the couA351 mutation. We disputed this and designated the coumarin sensitivity in XP222 as cou-392 (Welker & Williams, 1982a) . Table 4 shows that cou-392 is unlinked to two linkage group VII markers (cobA 1, bsgB500) and that it maps to linkage group I. Complementation tests established that the cou-392 mutation is not allelic with the couB352 mutation, the only other known coumarin-sensitivity mutation on linkage group I. 'Therefore we assign it to a new locus cod.
Mutations aflecting the cytoskeleton which appear not to be permeability mutations Unlike the five coumarin-sensitivity mutations described above, the couA35 1 and coup354 mutations may have a more specific defect, since they did not substantially alter sensitivity to cycloheximide (Table 3) . Both are associated with growth temperature sensitivity and cytoskeletal effects induced by elevated temperature, which are similar to those induced by coumarin (Welker & Williams, 1982a) . This contrasts with the putative permeability mutations Table 4 . Linkage analysis of haploid segregants of diploids heterozygous for the cod392 mutation
All of the segregants from these diploids were cycloheximide resistant, although some coumarinsensitive segregants were more sensitive to cycloheximide than the other segregants. The normal screening procedure only reveals large differences in plating efficiencies. Suppression of the cycloheximide resistance was clearer in segregants of DU25 14. Some variation of the coumarin-sensitive phenotype was also seen in these segregants. This presumably reflected genetic background effects which were consistent with a mutation on linkage group I1 or VII that suppressed coumarin sensitivity. It is possible that this effect was due to the acrA404 or cobAl mutation. Linkage group I of DU2640 was scored on the basis of the growth temperature sensitivity mutation tsgQ356. These diploids also contain an aggregation defect (agg-362) from XP222, which mapped to linkage group I11 or VI. Note that in segregants of DU2514 and DU2640 linkage groups I11 and VI cosegregated due to the presence of a translocation which is probably derived from NP187, a parent of XP222, and which may be T353(III,VI) (Welker eta/., 1982 Table 5 . Linkage analysis of haploid segregants of diploids heterozygous for the couJ360, couG370 or couH361 mutation
Segregants of DU2348 and DU2438 were obtained after thiabendazole-induced haploidization ; segregants of DU2351 were selected on 2% (v/v) methanol because of the thiabendazole sensitivity associated with the couH361 mutation. In all cases temperature sensitivity for growth, and for couG370 and couH361 altered spore shape, cosegregated with the coumarin sensitivity. One segregant containing a recombinant (whiB513, couG370) linkage group I11 was obtained from DU2438. DU2348 contains a translocation T360(II,VII) which causes the cosegregation of linkage groups I1 and VII ; this translocation may have been induced by nitrosoguanidine during the isolation of the couJ360 mutation. Complementation tests between pairwise combinations of the three coumarin-sensitivity mutations which map to linkage group I11 (couD355, cod360 and couG370) indicated that each affects a separate locus (D. L. Welker, unpublished data). Linkage group V was unmarked in these diploids. Table 6 . Genetic loci associated with altered resistance to microtubule inhibitors (including coumarin)
The effect of coumarin on the cytoskeleton is still unclear, but the results presented here coupled with previous studies (Welker & Williams, 1982a; Welker, 1982) strongly suggest some role. Three previously described spore shape mutations, sprAl (linkage group I), sprB2 (linkage group 11) and sprH351 (linkage group IV) are also putative cytoskeletal mutations, but probably are not associated with altered resistance to microtubule inhibitors. Similarly the five spore shape mutations associated with thiabendazole resistance may affect the cytoskeleton directly. These are spr-378, spr-379, spr-380, spr-38 1 and spr-382 of strains HU 1706 , HU 1755 , HU 1757 , HU 1758 , and HU 1760 .
The thiabendazole-resistance mutations with pleiotropic growth temperature sensitivities thi-35 1, thi-352, thi-353 and rhi-354 of strains HU1756, HU1775, HU1791 and HU1794, whose parents are, respectively, HU1206, HU526, HU526 and HU526, may also directly affect the cytoskeleton (this paper). The ben-359 and ben-360 mutations (this paper) are not classified as their effects are not fully established. couB352, couC356, couD355, couE353 and couI392 which, with the possible exception of couC356, are not associated with growth temperature sensitivity (Welker & Williams, 1982a) . A third coumarin-sensitivity mutation, which also appears to be associated with temperature sensitivity for growth, couJ360, had no substantial effect on cycloheximide resistance (Table 3) . This mutation, isolated in HUlO48 following mutagenesis of strain A X 3 with nitrosoguanidine, mapped to linkage group I11 (Table 5) .
Two further mutants, HUI 108 and HU1043, whose mutations (couG370 and couH361, respectively) map to loci on linkage groups I11 and IV (Table 5) are similarly candidates for specific cytoskeletal defects ( Table 3) . They were originally isolated on the basis of growth temperature sensitivity after mutagenesis of strain A X 3 with nitrosoguanidine (K. L. Williams & B. A. Metz, unpublished) . They were subsequently found to be sensitive to 1.3 mmcoumarin and to have altered spore shape (Fig. 1 ) . All three phenotypes map together. In addition, HU1043 was found to be sensitive to benlate (35 pg m1-I) and thiabendazole (2 pg ml-l) and this phenotype mapped with the couH361 mutation. Multiple linked mutations have not been Fig. 1 . Giemsa-stained spores of haploid strain AX3 (a); two mutants derived from AX3, HU1108 with round spores (6) and HU1043 with large spores (c). Cytological and genetic analyses confirmed that HU1043 was haploid. All photographs are at the same magnification; AX3 spores are about 7 pm long. rigorously excluded, but it is extremely unlikely that similar phenotypes, involving three or four new mutations, that map to a single linkage group, should arise twice.
Since in A . nidulans thiabendazole-resistance mutations with pleiotropic temperature sensitivities have been used to identify a gene for b-tubulin (Sheir-Neiss et al., 1978), similar mutations in D. discoideum may directly affect the cytoskeleton. Five of 61 spontaneous, independently derived, thiabendazole-resistant mutants isolated from strains A X 3 , HU526 and HU 1206 were also temperature sensitive. Preliminary genetic analyses of four of these mutants (Table 6 ) established that the mutations affect different loci and that these loci are different from the five known loci in which mutations lead to pleiotropic sensitivity to coumarin and growth at high temperatures (couA, couF, couG, couH, couJ).
Spore shupe mutations and the cytoskeleton
The observations (Fig. 1 ) that HU1043 (couH361) has larger than normal spores for a haploid and that H u l l 0 8 (couG370) has round spores suggest an association between the cytoskeleton and spore shape. This is supported by the finding that some spontaneous thiabendazole-resistant mutants carried new spore shape alterations. The chance of recovering multiple mutations in spontaneous mutants is very low. Of the sixty-one new thiabendazole-resistant mutants, five had an altered spore shape. One was round-spored, two were large-spored and two were thin-spored (Table 6 ). In plant cells microtubule organization affects the laying down of cellulose in the cell wall (Gunning & Hardham, 1982) and hence cell shape. We propose that similar processes may be involved in spore wall formation in D. discoideum and that alterations in spore shape reflect changes in microtubule organization.
Three loci have previously been found which affect spore shape: sprA (Katz & Sussman, 1972) , sprB (Mosses et al., 1975) , and sprH (Welker & Williams, 19826) . Mutations at these loci are also candidates for microtubule-specific mutations. The sprA locus is defined by the sprA 1 mutation whose phenotype is round spore shape, which is dominant to wild-type, although the dominance is suppressible in some genetic backgrounds (K. L. Williams, unpublished) . The sprA 1 mutation appears not to be associated with growth temperature sensitivity (Welker & Williams, 19826 ; K. L. Williams, unpublished) or altered resistance to microtubule inhibitors.
The sprB2 mutation defines the sprB locus. The phenotype is thin elliptical spores and it is the wild-type spore shape in strain V12 (Mosses et al., 1975) . The sprB2 allele is dominant to wildtype and it suppresses the sprH35 1 mutation. The sprH35 1 mutation is a recessive round-spore mutation discovered in strain M146, which also carries the acrD369 mutation. The acrD369 and sprH351 mutations affect different genes. The acrD369 mutation probably arose as a result of the same mutagenic treatment that led to the munA 1 mutation in strain M 1 , the parent of M 146. A second derivative of M 1 , strain M 137, carries the acrD369 but not the sprH35 1 mutation, both of which are present in M146.
In conclusion, mutations in D . discoideurn which affect resistance to antimicrotubule agents can be classified into two groups (Table 6) according to whether or not there are concurrent alterations in resistance to compounds unrelated to microtubule inhibitors (particularly acriflavin and cycloheximide). This classification will help systematize future genetic studies and focus biochemical studies on mutants which are strong candidates for specific microtubule alterations.
